(Source: iPharma Pharmacy, 2026) Tirzepatides Dual Mechanism May Offer a Compliance Advantage Because tirzepatide activates both GLP-1 and GIP receptors, researchers have hypothesized its dual mechanism may reduce the intensity of gastrointestinal side effects compared to single-receptor GLP-1 agonists a meaningful consideration since GI side effects are a leading cause of treatment discontinuation
Patients should also review other potential triggers, including new skincare products, detergents, or environmental allergens, which may coincide with starting Ozempic and contribute to pruritus
Step 2: Have a telehealth consult with a Hone doctor A Hone doctor will review your lab test results during a telehealth appointment
31 December 2019
The Increlex label specifies it should not be used by pregnant women
[10] Patients interested in weight management pharmacotherapy are encouraged to discuss options with their GP or a specialist obesity service, where evidence-based, licensed treatments can be prescribed safely within an appropriate clinical framework